Sec Form 4 Filing - Symphony Capital Partners LP @ OXIGENE INC - 2009-07-20

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Symphony Capital Partners LP
2. Issuer Name and Ticker or Trading Symbol
OXIGENE INC [ OXGN]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director X __ 10% Owner
_____ Officer (give title below) X __ Other (specify below)
See Footnote 2 and Remarks
(Last) (First) (Middle)
C/O SYMPHONY CAPITAL PARTNERS, L.P., 875 THIRD AVENUE, 18TH FLOOR
3. Date of Earliest Transaction (MM/DD/YY)
07/20/2009
(Street)
NEW YORK, NY10022
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
_____ Form filed by One Reporting Person
__ X __ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value .01 per share 07/20/2009 J( 1 ) 10,000,000 A 27,117,118 I See Footnote ( 2 )
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Symphony Capital Partners LP
C/O SYMPHONY CAPITAL PARTNERS, L.P.
875 THIRD AVENUE, 18TH FLOOR
NEW YORK, NY10022
X X See Footnote 2 and Remarks
SYMPHONY CAPITAL GP, L.P.
875 THIRD AVENUE
18TH FLOOR
NEW YORK, NY10022
X X See Footnote 2 and Remarks
SYMPHONY GP, LLC
875 THIRD AVENUE
18TH FLOOR
NEW YORK, NY10022
X X See Footnote 2 and Remarks
SYMPHONY ViDA HOLDINGS LLC
875 THIRD AVENUE
18TH FLOOR
NEW YORK, NY10022
X X See Footnote 2 and Remarks
TARANTO HARRI V
C/O SYMPHONY CAPITAL PARTNERS, L.P.
875 THIRD AVENUE, 18TH FLOOR
NEW YORK, NY10022
X X See Footnote 2 and Remarks
Signatures
/s/ Mark Kessel 08/12/2009
Signature of Reporting Person Date
/s/ Mark Kessel 08/12/2009
Signature of Reporting Person Date
/s/ Mark Kessel 08/12/2009
Signature of Reporting Person Date
/s/ Mark Kessel 08/12/2009
Signature of Reporting Person Date
/s/ Harri V. Taranto 08/12/2009
Signature of Reporting Person Date
Explanation of Responses:
( 1 )The common stock reported herein was issued by OXiGENE, Inc. (the "Issuer") to Symphony ViDA Holdings LLC ("Holdings") in connection with the exercise by the Issuer of a purchase option under the Amended and Restated Purchase Option Agreement (the "Purchase Option Agreement"), dated as of July 2, 2009, by and among the Issuer, Holdings and Symphony ViDA, Inc. ("Vida"), pursuant to which the Issuer had the right to repurchase certain intellectual property related to two of the Issuer's product programs.
( 2 )Includes 27,117,118 shares of common stock directly owned by Holdings. Symphony Capital Partners, L.P. ("SCP L.P.") is the manager of Holdings; Symphony GP, LLC ("SGP LLC") is the general partner of Symphony Capital GP, L.P. ("SC GP L.P."), which is the general partner of SCP L.P. (collectively, the "Symphony Entities"). Mark Kessel and Harri V. Taranto are managing members of SGP LLC. Mr. Kessel, Mr. Taranto and the Symphony Entities are referred to as the "Reporting Persons." Mr. Kessel is also a member of the Issuer's board of directors. As such, the Reporting Persons other than Mr. Kessel may be deemed to be a director of the Issuer by deputization.

Remarks:
The reporting persons may be deemed to be a member of a "group" for purposes of the Securities Exchange Act of 1934, as amended. The reporting persons disclaim beneficial ownership of any securities deemed to be owned by the group that are not directly owned by such reporting persons. This report shall not be deemed an admission that any reporting person is a member of a group or the beneficial owner of any securities not directly owned by the reporting persons.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.